结论：心达康胶囊治疗冠心病心绞痛(胸痹心血瘀阻证)安全、有效。
CONCLUSION: Xindakang capsule is an effective and safe drug in treating angina pectoris.
心血瘀阻证、痰阻心脉证和心阴亏虚证等证候为冠心病患者的主要证候特点。
The syndrome types are mostly heart blood stasis syndrome, heart collaterals obstruction due to phlegm accumulation syndrome and heart-Yin deficiency syndrome.
目的：评价心达康胶囊治疗冠心病心绞痛(胸痹心血瘀阻证)的临床疗效与安全性。
AIM: to evaluate the efficacy and safety of xindakang capsules in the treatment of patients with angina pectoris.
目的：评价心达康胶囊治疗冠心病心绞痛(胸痹心血瘀阻证)的临床疗效与安全性。
AIM: to evaluate the efficacy and safety of xindakang capsules in the treatment of patients with angina pectoris.
应用推荐